{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:43:56Z","timestamp":1791895436828,"version":"4.3.4"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Hearing loss is the most common sensory disorder, significantly affecting the quality of life for millions of people worldwide. Chemical chaperones are emerging as a potential therapeutic option for hereditary forms of deafness associated with protein misfolding. VRT534, a chemical chaperone previously used in the treatment of cystic fibrosis, has been shown to modulate the activity of mutated forms of human connexin 26 (Cx26), a gap junction protein crucial for auditory function. However, the precise molecular mechanism of its interaction with Cx26 remains unclear. In this study, we investigated the ability of VRT534 to bind and functionally rescue mutant Cx26. Structural models of Cx26 were generated using AlphaFold3 and analyzed via Diff-Dock-L for binding prediction. Functional restoration by VRT534 was tested using an automated patch-clamp in HeLa cells expressing wild-type or mutant Cx26 (Cx26WT, Cx26L90P, Cx26F161S, and Cx26R184P). VRT534 restored channel function in Cx26L90P and Cx26R184P, but not in Cx26F161S. Docking data revealed stronger binding affinity of VRT534 to mutant variants, with putative binding sites located near the pore region. These findings provide new insight into the selective rescue of mutant Cx26 and support further development of chemical chaperones for hereditary hearing loss.<\/jats:p>","DOI":"10.3389\/fmed.2025.1607598","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T05:43:54Z","timestamp":1758692634000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the binding sites of VRT534 at Cx26 as a putative chemical chaperone for targeted treatment of hereditary hearing disorders"],"prefix":"10.3389","volume":"12","author":[{"given":"Jennifer","family":"Harre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Warnecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Zeilinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1056\/NEJMra050700","article-title":"Newborn hearing screening\u2014a silent revolution","volume":"354","author":"Morton","year":"2006","journal-title":"N Engl J Med."},{"key":"B2","volume-title":"Global Costs of Unaddressed Hearing Loss and Cost-Effectiveness of Interventions: A WHO Report","year":"2017"},{"key":"B3","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/S0140-6736(21)00516-X","article-title":"Hearing loss prevalence and years lived with disability, 1990-2019: findings from the global burden of disease study 2019","volume":"397","author":"GBD","year":"2021","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S0140-6736(05)71047-3","article-title":"Sensorineural hearing loss in children","volume":"365","author":"Smith","year":"2005","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/00125817-200207000-00004","article-title":"GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: a HuGE review","volume":"4","author":"Kenneson","year":"2002","journal-title":"Genet Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neuroscience.2025.02.027","article-title":"Regulatory mechanisms of connexin26","volume":"570","author":"Ke","year":"2025","journal-title":"Neuroscience."},{"key":"B7","doi-asserted-by":"publisher","first-page":"149326","DOI":"10.1016\/j.gene.2025.149326","article-title":"Mechanisms of congenital hearing loss caused by GJB2 gene mutations and current progress in gene therapy","volume":"946","author":"Ma","year":"2025","journal-title":"Gene."},{"key":"B8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1085\/jgp.201611585","article-title":"Syndromic deafness mutations at ASN 14 differentially alter the open stability of Cx26 hemichannels","volume":"148","author":"Sanchez","year":"2016","journal-title":"J Gen Physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e70916","DOI":"10.1371\/journal.pone.0070916","article-title":"Analysis of trafficking, stability and function of human connexin 26 gap junction channels with deafness-causing mutations in the fourth transmembrane helix","volume":"8","author":"Ambrosi","year":"2013","journal-title":"PLoS ONE."},{"key":"B10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.nbd.2014.09.005","article-title":"Timed conditional null of connexin26 in mice reveals temporary requirements of connexin26 in key cochlear developmental events before the onset of hearing","volume":"73","author":"Chang","year":"2015","journal-title":"Neurobiol Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bbrc.2017.05.137","article-title":"Progressive age-dependence and frequency difference in the effect of gap junctions on active cochlear amplification and hearing","volume":"489","author":"Zong","year":"2017","journal-title":"Biochem Biophys Res Commun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neulet.2012.08.085","article-title":"Cell degeneration is not a primary causer for connexin26 (GJB2) deficiency associated hearing loss","volume":"528","author":"Liang","year":"2012","journal-title":"Neurosci Lett."},{"key":"B13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbrc.2014.04.016","article-title":"Deafness induced by Connexin 26 (GJB2) deficiency is not determined by endocochlear potential (EP) reduction but is associated with cochlear developmental disorders","volume":"448","author":"Chen","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.nbd.2017.08.002","article-title":"A deafness mechanism of digenic Cx26 (GJB2) and Cx30 (GJB6) mutations: reduction of endocochlear potential by impairment of heterogeneous gap junctional function in the cochlear lateral wall","volume":"108","author":"Mei","year":"2017","journal-title":"Neurobiol Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1021\/acsptsci.3c00056","article-title":"Chemical chaperone restores connexin 26 mutant activity","volume":"6","author":"Wang","year":"2023","journal-title":"ACS Pharmacol Transl Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.bbapap.2006.08.012","article-title":"Small molecule pharmacological chaperones: from thermodynamic stabilization to pharmaceutical drugs","volume":"1764","author":"Arakawa","year":"2006","journal-title":"Biochim Biophys Acta."},{"key":"B17","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1080\/14728222.2019.1628948","article-title":"Cystic fibrosis: proteostatic correctors of CFTR trafficking and alternative therapeutic targets","volume":"23","author":"Hanrahan","year":"2019","journal-title":"Expert Opin Ther Targets."},{"key":"B18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jcf.2023.07.006","article-title":"Traits, trends and hits of orphan drug designations in cystic fibrosis","volume":"22","author":"Costa","year":"2023","journal-title":"J Cyst Fibros."},{"key":"B19","first-page":"379","article-title":"Moderate hearing loss and pseudodominant inheritance due to L90P\/35delG mutations in the GJB2 (connexin 26) gene","volume":"14","author":"Tekin","year":"2003","journal-title":"Genet Couns."},{"key":"B20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fncel.2015.00202","article-title":"Cellular and deafness mechanisms underlying connexin mutation-induced hearing loss-a common hereditary deafness","volume":"9","author":"Wingard","year":"2015","journal-title":"Front Cell Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.str.2021.05.010","article-title":"Cryo-EM structure of an open conformation of a gap junction hemichannel in lipid bilayer nanodiscs","volume":"29","author":"Khan","year":"2021","journal-title":"Structure"},{"key":"B22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.str.2022.02.010","article-title":"Conformational changes and CO2-induced channel gating in connexin26","volume":"30","author":"Brotherton","year":"2022","journal-title":"Structure"},{"key":"B23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/biology13050298","article-title":"Connexin gap junction channels and hemichannels: insights from high-resolution structures","volume":"13","author":"Jagielnicki","year":"2024","journal-title":"Biology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/ejhg.2008.179","article-title":"Functional consequences of novel connexin 26 mutations associated with hereditary hearing loss","volume":"17","author":"Mani","year":"2009","journal-title":"Eur J Hum Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mcn.2010.10.002","article-title":"Dominant Cx26 mutants associated with hearing loss have dominant-negative effects on wild type Cx26","volume":"47","author":"Zhang","year":"2011","journal-title":"Mol Cell Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature."},{"key":"B28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ppul.20200","article-title":"Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy","volume":"40","author":"Kerem","year":"2005","journal-title":"Pediatr Pulmonol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1021\/pr050319o","article-title":"Pharmacoproteomics of 4-phenylbutyrate-treated IB3-1 cystic fibrosis bronchial epithelial cells","volume":"5","author":"Singh","year":"2006","journal-title":"J Proteome Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1210\/me.2008-0384","article-title":"Molecular mechanism of action of pharmacoperone rescue of misrouted GPCR mutants: the GnRH receptor","volume":"23","author":"Janovick","year":"2009","journal-title":"Mol Endocrinol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"32674","DOI":"10.1074\/jbc.M404455200","article-title":"Mutants in a small heat shock protein that affect the oligomeric state. Analysis and allele-specific suppression","volume":"279","author":"Giese","year":"2004","journal-title":"J Biol Chem."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2402.18396","article-title":"Deep confident steps to new pockets: strategies for docking generalization","author":"Corso","year":"2024","journal-title":"arXiv [preprint]."},{"key":"B33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2144\/btn-2023-0070","article-title":"Predicting molecular docking of per- and polyfluoroalkyl substances to blood protein using generative artificial intelligence algorithm diffdock","volume":"76","author":"Fortela","year":"2024","journal-title":"Biotechniques"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2210.01776","article-title":"DiffDock: diffusion steps, twists, and turns for molecular docking","author":"Corso","year":"","journal-title":"arXiv [preprint]."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock vina 120: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J Chem Inf Model."},{"key":"B36","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1607598\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T05:43:55Z","timestamp":1758692635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1607598\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":36,"alternative-id":["10.3389\/fmed.2025.1607598"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1607598","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"article-number":"1607598"}}